Giuffre Randall Michael's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Dec 5, 2022
- Accession no.
- 0001235802-22-000129
- Filed
- Dec 5, 2022
- Trade date
- Dec 1, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $974.61. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Giuffre Randall MichaelCIK 0001759822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Voting Common Shares, no par value per share | PPurchaseAcquired | +819 | $1.19 | +$974.61 | 178,272 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.